List view / Grid view
The companies have agreed to jointly develop and commercialise long-acting,…
The companies have agreed to jointly develop and commercialise long-acting, investigational treatment combinations of lenacapavir and islatravir for HIV.
Pharma executives are committed to bringing drugs to market to…
Pharma executives are committed to bringing drugs to market to improve the lives of patients but is the industry too introspective to be truly innovative?
Lilly, Merck and Pfizer have announced how they will enable…
Lilly, Merck and Pfizer have announced how they will enable their employees to volunteer in programmes to combat COVID-19 while on base pay.
Merck announced the future appointment of Michael J. Holston as…
25 June 2014 | By Merck
Merck announced the future appointment of Michael J. Holston as general counsel, effective July 01, 2015...
Merck announced the appointment of Robert M. Davis as executive…
27 March 2014 | By Merck
Merck announced the appointment of Robert M. Davis as executive vice president and chief financial officer, effective April 23, 2014....
“We’re taking significant and decisive action to make Merck a…
13 January 2014 | By Merck
“We’re taking significant and decisive action to make Merck a more competitive company, better positioned to drive innovation and growth...”
Merck's board of directors has authorized additional purchases of up…
1 May 2013 | By Merck
Merck's board of directors has authorized additional purchases of up to $15 billion of Merck’s common stock for its treasury.
Merck (NYSE: MRK), known as MSD outside the United States…
7 March 2013 | By Merck
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment of Roger M. Perlmutter, M.D., Ph.D., as executive vice president and president of Merck Research Laboratories (MRL), effective April 15. Dr. Perlmutter will succeed Peter S. Kim, Ph.D., who has served in the role…
World Health Organization commends the MECTIZAN® Donation Program on its…
11 October 2012 | By Merck
World Health Organization commends the MECTIZAN® Donation Program on its contribution to near-elimination of river blindness from the Western Hemisphere...
Merck has announced plans to move the company's global headquarters…
9 October 2012 | By Merck
Merck has announced plans to move the company's global headquarters within the state...
Long-time Merck and Schering-Plough Executive Richard S. Bowles to retire...
28 March 2012 | By Merck
Long-time Merck and Schering-Plough Executive Richard S. Bowles to retire...
New Brazilian joint venture to combine local and global commercial…
15 February 2012 | By Merck
New Brazilian joint venture to combine local and global commercial expertise...
Merck is hosting a R&D and Business Briefing...
11 November 2011 | By Merck
Merck is hosting a R&D and Business Briefing...
Merck announced that Richard T. Clark, chairman, will retire 1st…
6 October 2011 | By Merck
Merck announced that Richard T. Clark, chairman, will retire 1st December ...
Merck and Johnson & Johnson and its subsidiary Centocor Ortho…
15 April 2011 | By Merck
Merck and Johnson & Johnson and its subsidiary Centocor Ortho Biotech Inc., announced that the companies have reached an agreement...
